Semi-Annual Consolidated Statement Of Income

Fuso Pharmaceutical Industries,Ltd. - Filing #7594726

Concept 2022-04-01 to
2022-06-30
2021-04-01 to
2021-06-30
Semi-annual consolidated statement of income
Statement of income
Net sales
12,367,000,000 JPY
12,599,000,000 JPY
Cost of sales
8,849,000,000 JPY
9,134,000,000 JPY
Ordinary profit (loss)
774,000,000 JPY
780,000,000 JPY
Gross profit (loss)
3,518,000,000 JPY
3,465,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
2,895,000,000 JPY
2,853,000,000 JPY
Extraordinary losses
0 JPY
0 JPY
Operating profit (loss)
622,000,000 JPY
612,000,000 JPY
Profit (loss) before income taxes
774,000,000 JPY
780,000,000 JPY
Income taxes - current
42,000,000 JPY
10,000,000 JPY
Non-operating income
Non-operating income
221,000,000 JPY
241,000,000 JPY
Non-operating expenses
Interest expenses
39,000,000 JPY
43,000,000 JPY
Non-operating expenses
69,000,000 JPY
73,000,000 JPY
Income taxes - deferred
172,000,000 JPY
222,000,000 JPY
Income taxes
214,000,000 JPY
232,000,000 JPY
Profit (loss)
559,000,000 JPY
547,000,000 JPY
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.